Top Buy
Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Neurocrine Bioscience | 46 | 0 | 11 | 0 | €114.70 | €149.74 | 30.546% |
Alnylam Pharmace. | 46 | 0 | 8 | 0 | €234.40 | €271.88 | 15.990% |
Tenet Healthcare | 42 | 0 | 4 | 0 | €149.00 | €154.91 | 3.968% |
Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €14.13 | €29.92 | 111.790% |
Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €105.00 | €183.41 | 74.680% |
Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | €43.71 | €56.72 | 29.768% |
United Therapeutics | 27 | 1 | 5 | 1 | €328.10 | €341.51 | 4.087% |
Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | €51.00 | €84.74 | 66.165% |
Icon plc | 24 | 0 | 0 | 0 | €289.40 | €326.21 | 12.720% |
Halozyme Therapeutics Inc. | 23 | 0 | 5 | 0 | €57.58 | €56.00 | -2.747% |
Merit Medical Systems | 22 | 0 | 3 | 0 | €86.00 | €90.45 | 5.179% |
Exelixis Inc. | 21 | 0 | 3 | 0 | €23.23 | €26.01 | 11.952% |
Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | €10.39 | €26.24 | 152.634% |
Arrowhead Pharmaceuticals Inc. | 18 | 2 | 1 | 0 | €21.26 | €55.13 | 159.332% |
Alkermes plc | 17 | 2 | 0 | 0 | €25.40 | €35.01 | 37.847% |
Molina Healthcare | 17 | 1 | 2 | 0 | €316.40 | €370.26 | 17.023% |
Insulet Corp. | 16 | 0 | 2 | 0 | €182.85 | €215.54 | 17.877% |
Medpace Holdings Inc | 16 | 0 | 0 | 0 | €322.60 | €418.12 | 29.610% |
CONMED Corp. | 15 | 2 | 4 | 0 | €63.00 | €98.42 | 56.219% |
PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | €31.60 | €41.51 | 31.369% |
Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |
Charles River Labs Intl | 13 | 0 | 2 | 0 | €176.75 | €247.61 | 40.089% |
LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
Amedisys Inc. | 11 | 0 | 0 | 0 | €87.00 | €92.26 | 6.046% |